La crosse virus encephalitis preceding neurosarcoidosis diagnosed by brain biopsy

Pediatrics

Volumn 127, Issue 4, 2011, Pages

  Kobayashi, Daisuke ^a   Rouster Stevens, Kelly ^b   Harper, Amy ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Brain biopsy; Encephalitis; La Crosse virus; Neurosarcoid

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

APHASIA; ARTICLE; ATAXIA; BRAIN BIOPSY; CALIFORNIA ENCEPHALITIS; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; FEVER; GRANULOMATOUS INFLAMMATION; HEADACHE; HUMAN; LA CROSSE VIRUS; LOFGREN SYNDROME; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SCHOOL CHILD; SEIZURE;

BIOPSY; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; ENCEPHALITIS, CALIFORNIA; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; LA CROSSE VIRUS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953330818     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-0615     Document Type: Article

References (33)

1. McJunkin JE, Khan RR, Tsai TF. California- La Crosse encephalitis. Infect Dis Clin North Am. 1998;12(1):83-93
2. Haddow AD, Odoi A. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007. PLoS One. 2009; 4(7):e6145
3. Hall-Baker PA, Nieves E, Jajosky RA, et al; Centers for Disease Control and Prevention. Summary of notifiable diseases: United States, 2007 [published correction appears in MMWR Morb Mortal Wkly Rep. 2009; 56(53)].MMWRMorb Mortal Wkly Rep. 2009; 56(53):1-94
4. Sokol DK, Kleiman MB, Garg BP. LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. Pediatr Neurol. 2001;25(5): 413-415 (Pubitemid 34016001)
5. McJunkin JE, Khan R, de los Reyes EC, Parsons DL, Minnich LL, Ashley RG, Tsai TF. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics. 1997; 99(2):261-267
6. Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J. 2008;6:16
7. Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004;93(1):30-36
8. Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001;248(5):363-372 (Pubitemid 32477326)
9. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009;102(7):449-460
10. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69(5):261-276 (Pubitemid 20360035)
11. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis: diagnosis and management. QJM. 1999;92(2):103-117 (Pubitemid 29097635)
12. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med. 2001;344(11):801-807
13. Balkhy HH, Schreiber JR. Severe La Crosse encephalitis with significant neurologic sequelae. Pediatr Infect Dis J. 2000;19(1):77-80 (Pubitemid 30046622)
14. de los Reyes EC, McJunkin JE, Glauser TA, Tomsho M, O'Neal J. Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome. J Child Neurol. 2008;23(2):167-172
15. Centers for Disease Control and Prevention. Neuroinvasive and non-neuroinvasive domestic arboviral diseases: 2004 case definition. Available at: www.cdc.gov/ncphi/disss/nndss/casedef/arboviral-2004.htm. Accessed February 9, 2011
16. McJunkin JE, Minnich LL, Tsai TE. La Crosse encephalitis and other California serogroup viruses. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: W.B. Saunders; 2004:2403-2411
17. Baumann RJ, Robertson WC Jr. Neurosarcoid presents differently in children than in adults. Pediatrics. 2003;112(6 pt 1). Available at: www.pediatrics.org/cgi/content/full/112/6/e480
18. Pickuth D, Spielmann RP, Hyewang-Kobrunner SH. Role of radiology in the diagnosis of neurosarcoidosis. Eur Radiol. 2000; 10(6):941-944 (Pubitemid 30353727)
19. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997; 157(16):1864-1868 (Pubitemid 27381119)
20. Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest. 2003;124(5):2023-2026 (Pubitemid 37433608)
21. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol. 2007;64(5): 691-696 (Pubitemid 46789835)
22. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995;52(9):875-879
23. Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol. 2003;148(1):147-148 (Pubitemid 36114877)
24. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurologic involvement. Arch Neurol. 1998;55(9): 1248-1254 (Pubitemid 28427497)
25. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005; 127(3):1064-1071 (Pubitemid 40775543)
26. Toth C, Martin L, Morrish W, Coutts S, Parney I. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab. Acta Neurol Scand. 2007;116(4): 259-262 (Pubitemid 47373480)
27. Rybicki BA, Iannuzzi MC, Frederick MM, et al; ACCESS Research Group. Familial aggregation of sarcoidosis: A Case-Control Etiologic Study of Sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11):2085-2091 (Pubitemid 34020250)
28. Newman LS, Rose CS, Bresnitz EA, et al; ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324-1330 (Pubitemid 39657197)
29. Costabel U, Hunninghake GW. ATS/ERS/ WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4):735-737
30. Fauroux B, Clément A. Paediatric sarcoidosis. Paediatr Respir Rev. 2005;6(2):128-133 (Pubitemid 40692050)
31. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):36-52
32. Viñas JM, Gonzalez MJ, Ribes AG, Expósito RG, Bragado FG. Postencephalitic chronic granulomatous disease. Pediatr Neurol. 2006;35(4):297-299
33. Reyes MG, Fresco R, Chokroverty S, Salud EQ. Virus-like particles in granulomatous angiitis of the central nervous system. Neurology. 1976;26(8):797-799